Thursday, December 05, 2024 9:35:45 PM
Not annoying, these are your questions to answer. I'm not invested. I'm sure some of the buying is RONN insiders doing a bit of buying at inflated prices at the end of the trading day to help pump the idea that there is still hope. A poster earlier said 'nice day' and you gave the post an upvote. I'm assuming this is because RONN closed at .0005.
Pink Sheet stocks don't have to disclose buyers and sellers, there's no way for us to know why a stock trading at .0002 earlier in the day closed at .0005 with multiple trades of $25 and $50 and $100 each in the last 10 minutes of the trading day. At best, it's suspect.
Pink Sheet stocks don't have to disclose buyers and sellers, there's no way for us to know why a stock trading at .0002 earlier in the day closed at .0005 with multiple trades of $25 and $50 and $100 each in the last 10 minutes of the trading day. At best, it's suspect.
Rule #1, Don't lose money. Rule #2, read rule #1. - WB.
Recent AIMN News
- The Quiet Restructuring of Healthcare Intelligence: Why the Industry is Moving Toward Verified Professional Networks Over Anonymous AI • ACCESS Newswire • 05/20/2026 12:30:00 PM
- Inside AimwellBio's Federated Health Intelligence Network: Verified Clinical Intelligence Model Gains Attention Among Physicians • ACCESS Newswire • 05/18/2026 12:30:00 PM
- The Doctors Saw It First. Then the Chiropractors Asked. Now AimwellBio is Adding the Four Signals Every Family in America is Quietly Searching For. • ACCESS Newswire • 05/13/2026 12:30:00 PM
- Aimwell Partners Brand, AimwellBio Announces Expanded FHIN Intelligence Framework, Early Demo Feedback, and New AIMN Development Milestones • ACCESS Newswire • 05/11/2026 12:30:00 PM
- While You Were in That Meeting, 14 Signals Moved. Your Competitors Saw Them. You Didn’t. • ACCESS Newswire • 05/06/2026 12:30:00 PM
- AimwellBio Reports Strong Early Demand From Hospital Systems and Researchers as FHIN Founding Cohort Takes Shape • ACCESS Newswire • 05/04/2026 12:30:00 PM
- AimwellBio Launches Verified Intelligence Layer for Healthcare as AI Hallucination Risk Reaches Clinical Settings • ACCESS Newswire • 04/27/2026 12:30:00 PM
- Aimwell Bio Expands FHIN Deployment Across U.S. and Australia as Clinical Leaders Move to Replace Unverified AI Hospitalists and Physician Groups Drive Demand for Source-Traceable Intelligence Infrastructure • ACCESS Newswire • 04/22/2026 12:30:00 PM
- Aimwell Bio Announces "Founding Cohort" of Federated Health Intelligence Network (FHIN); Tackles 38% AI Hallucination Rate in Biopharma • ACCESS Newswire • 04/20/2026 12:30:00 PM
- AimwellBio Launches the System That Catches What AI Gets Wrong: Before It Reaches Patients, Boards, or Your Portfolio • ACCESS Newswire • 04/15/2026 12:30:00 PM
